Le Lézard
Classified in: Health

Unique take on depression has people feeling good--about feeling bad


DOVER, Del., Oct. 13, 2019 /PRNewswire-PRWeb/ -- "It was very unexpected," says author Everett De Morier. "This article took on a life of its own."

Everett De Morier is a humorist and award-winning author who, for the past three years, has been editor-in-chief of 543 Magazine. And this week, De Morier posted an article about depression in middle-aged people.

"I mean, the piece was a lot more personal than I like to get," said De Morier. "I had to admit some things that I was struggling with, but overall I expected it to be read by the same amount of readers as all the other articles."

543 Magazine has a solid number of loyal readers and even had its best-of articles turned into a book called The Invention of Everything: Insights on Life, Food, and One Good Thermos, published in 2018 by Blydyn Square Books. 543 Magazine also produced the 2018 documentary Binghamton: Valley of Creativity.

But the reaction to the article entitled "The Depression Agreement" was completely unexpected.

De Morier said, "The website had a small number of direct comments to the articles. People don't usually comment on the site; they share on social media. But shortly after the article went live, my email exploded."

In two days, "The Depression Agreement" received five times as many comments as the entire website had garnered in over three years. All of them were extremely positive.

"I guess it shows how important a topic depression is, but more importantly I think people responded to the fact that depression is a kind of a selfish act and we need to change that. And we do that be staying involved with those around us which leads to us actually feeling sort of good about feeling bad."

"The Depression Agreement" article can be found at https://543magazine.com/the-depression-agreement/#disqus_thread

 

SOURCE EverettDeMorier.com


These press releases may also interest you

at 07:05
Three major challenges poised to confront the nation's clinical laboratories, genetic test companies, and anatomic pathology laboratories will be major topics when a top-flight roster of lab experts, innovators, and lab leaders gather in New Orleans...

at 07:05
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that second quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday,...

at 07:04
Merck , known as MSD outside the United States and Canada, announced that Health Canada has granted approval of  KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with fluoropyrimidine- and platinum-containing-chemotherapy, for the...

at 07:00
Globe Life Inc. will release First Quarter 2024 earnings after the market closes on Monday, April 22, 2024.  At that time, a copy of the Company's First Quarter 2024 earnings press release and any other financial and statistical information about...

at 07:00
GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has granted the clinical trial approval for GFH925 (KRAS G12C inhibitor) in a...

at 07:00
César A. Lara, MD, introduces a groundbreaking solution for pain relief in the Tampa Bay area. Red Laser Therapy leverages the power of medical-grade red laser light to effectively address various types of pain, providing patients with a noninvasive...



News published on and distributed by: